Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/8091| Title: | Novel anticoagulants in atrial fibrillation: focused update | Authors: | Poposka, Lidija | Keywords: | atrial fibrillation | Issue Date: | 15-Jul-2013 | Publisher: | European Society of Cardiology | Journal: | e-Journal of Cardiology Practice | Abstract: | Novel oral anticoagulants are safer than Vitamin K antagonists (warfarin) in respect to the occurrence of bleeding, especially in terms of intracranial hemorrhage. Furthermore they are non-inferior and to a certain degree are superior in comparison to warfarin, when it comes to the prevention of ischemic stroke in patients with atrial fibrillation (AF). | URI: | http://hdl.handle.net/20.500.12188/8091 |
| Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Novel anticoagulants in atrial fibrillation focused update.pdf | 114.5 kB | Adobe PDF |  View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.